Tenax Therapeutics Analyst Ratings
Tenax Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Tenax Therapeutics (TENX) rating was a reiterated with a price target of $0.00 to $6.00. The current price Tenax Therapeutics (TENX) is trading at is $0.61, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 890.59% | Roth MKM | → $6 | Reiterates | Buy → Buy |
| 03/07/2023 | 890.59% | Roth MKM | → $6 | Initiates Coverage On | → Buy |
| 12/29/2020 | 725.49% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/13/2023 | 890.59% | Roth MKM | → 6 美元 | 重申 | 购买 → 购买 |
| 03/07/2023 | 890.59% | Roth MKM | → 6 美元 | 启动覆盖范围开启 | → 购买 |
| 12/29/2020 | 725.49% | HC Wainwright & Co. | → 5 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for Tenax Therapeutics (TENX)?
Tenax Therapeutics（TENX）的目标价格是多少？
The latest price target for Tenax Therapeutics (NASDAQ: TENX) was reported by Roth MKM on November 13, 2023. The analyst firm set a price target for $6.00 expecting TENX to rise to within 12 months (a possible 890.59% upside). 2 analyst firms have reported ratings in the last year.
罗斯MKM于2023年11月13日公布了Tenax Therapeutics（纳斯达克股票代码：TENX）的最新目标股价。该分析公司将目标股价定为6.00美元，预计TENX将在12个月内升至12个月内（可能上涨890.59％）。去年有两家分析公司公布了评级。
What is the most recent analyst rating for Tenax Therapeutics (TENX)?
Tenax Therapeutics（TENX）的最新分析师评级是多少？
The latest analyst rating for Tenax Therapeutics (NASDAQ: TENX) was provided by Roth MKM, and Tenax Therapeutics reiterated their buy rating.
Roth MKM提供了Tenax Therapeutics（纳斯达克股票代码：TENX）的最新分析师评级，Tenax Therapeutics重申了买入评级。
When is the next analyst rating going to be posted or updated for Tenax Therapeutics (TENX)?
Tenax Therapeutics（TENX）的下一次分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenax Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenax Therapeutics was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Tenax Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Tenax Therapeutics的最新评级是在2023年11月13日公布的，因此您应该预计下一个评级将在2024年11月13日左右公布。
Is the Analyst Rating Tenax Therapeutics (TENX) correct?
分析师对Tenax Therapeutics（TENX）的评级是否正确？
While ratings are subjective and will change, the latest Tenax Therapeutics (TENX) rating was a reiterated with a price target of $0.00 to $6.00. The current price Tenax Therapeutics (TENX) is trading at is $0.61, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但Tenax Therapeutics（TENX）的最新评级得到了重申，目标股价为0.00美元至6.00美元。Tenax Therapeutics（TENX）目前的交易价格为0.61美元，在分析师的预测区间内。
